Similar Articles |
|
BusinessWeek July 21, 2003 William C. Symonds |
Boston: A Graveyard Smash Welcome to "Ghosts & Gravestones," a thoroughly entertaining and educational tour of the macabre side of Boston's rich history. |
Financial Planning July 1, 2012 |
Women Advisors Forum/Boston: Growing Networks The financial planning industry is waking up to the fact that women advisors possess unique skills they can leverage to build strong practices. |
The Motley Fool March 16, 2005 Jeremy MacNealy |
A Market-Beating Lager-naut? There's much to like about Boston Beer, but a pricey stock cautions to invest responsibly. |
The Motley Fool January 17, 2007 Tom Taulli |
Boston Market: Still a Turkey McDonald's bought Boston Market to diversify. Now it's thinking about selling the chain. |
The Motley Fool May 28, 2004 W.D. Crotty |
Boston Scientific's Stent Gold Mine The company is starting two or more years of high profitability. |
The Motley Fool May 25, 2005 Stephen D. Simpson |
Stent Wars 2: The Market-Share Menace The battle for drug-coated stent market share between Johnson & Johnson and Boston Scientific may not be as exciting as watching Obi-Wan Kenobi and Anakin Skywalker fight, but the outcome matters for investors. |
Home Theater May 26, 2010 Mark Fleischmann |
Outdoor Speakers Discounted Boston Acoustics offers 20 percent off through July 31, 2010. |
The Motley Fool September 14, 2011 Brian Orelli |
How to Muck Up a Turnaround in 12 and a Half Months Boston Scientific's choice for a new CEO has the potential to really muck up its recovery even further -- if that's even possible. |
The Motley Fool April 23, 2008 Brian Orelli |
Boston Scientific Gets It Done After a rough 2007, it looks like Boston Scientific is turning itself around from the bottom up. |
InsideFlyer March 2012 |
AAdvantage Double Miles to Japan American AAdvantage members can earn double miles every time they fly the new nonstop service between Boston and Tokyo with qualifying business class and select economy fares between April 22 and June 30, 2012. |
The Motley Fool May 2, 2011 Brian Stoffel |
Costco's Living On the Edge Here are two metrics to focus on for growth in this sector. |
The Motley Fool July 23, 2008 Brian Orelli |
Leaner Boston Scientific Isn't Looking Healthy Investors are rightfully growing weary of Boston Scientific's ability to cut expenses on flat sales, and they send the stock down. |
The Motley Fool January 5, 2007 Mary Dalrymple |
Work on Your Waist Without Waste Make sure you get your money's worth from a gym membership. |
The Motley Fool January 31, 2005 Jeremy MacNealy |
A Tweeter With Big Bass Boston Acoustics' quarterly results sound good, but is there steady growth? |
The Motley Fool July 21, 2010 Brian Orelli |
Boston Scientific Bounces When you're as beaten-down as Boston Scientific, you seemingly have nowhere to go but up. There's also bankruptcy, but the beleaguered medical device maker seems far from that -- at least for now. |
The Motley Fool April 9, 2010 Brian Orelli |
Is Boston Scientific Turning It Around? Selling off a pair of units could help. |
The Motley Fool April 19, 2005 Stephen D. Simpson |
Stent Success Propels Boston Scientific The medical device company's still ahead of the competition. Companies dependent upon one product line may be riskier than average, but there's no question that they can reap big-time profits when business is good. |
Real Estate Portfolio May/Jun 2001 |
A Taste for the Classics Whether it's developing and managing great properties like the Embarcadero Center in San Francisco or 5 Times Square in New York City, or working with the board of the Boston Symphony Orchestra, Boston Properties' Ed Linde has shown a taste for the classics... |
The Motley Fool June 13, 2005 Timothy M. Otte |
Costco's Healthy Values Bulk toilet paper, widescreen TVs, frozen lasagna -- and health insurance? For investors, this is just another sign of Costco's commitment to providing value. |
U.S. Banker September 2009 |
FreshInk The latest mergers and acquisitions in the banking industry. |
The Motley Fool November 6, 2009 Robert Steyer |
Boston Beer's Blast of a Quarter While major brewers worry about consumers trading down to cheaper brands, Boston Beer is moving up -- in profit, in revenue, in full-year forecast and, after reporting, in share price. |
The Motley Fool February 7, 2006 Stephen D. Simpson |
Boston Scientific's Big Task The company won the battle for Guidant, but the hard work hasn't even begun. Value is value, and if Boston Scientific proves it can handle the considerable challenges ahead, this could ultimately be a very interesting stock again. |
Financial Planning March 1, 2013 |
Women Advisors Forum: Build Specialized Skills Many women say their current financial professionals don t measure up. Shouldn't you be offering your services instead? |
The Motley Fool October 13, 2008 Brian Orelli |
Too Little Too Late for Boston Scientific The company gets new stent approved, but it should have happened earlier. |
Bank Systems & Technology March 7, 2005 |
Exec News Boston Private Adds to Senior Management Team... M&I Chief Risk Officer... First State Appoints Stanford to Fed Board... etc. |
Job Journal June 13, 2010 Daniel Sitter |
8 Habits of Highly Successful Salespeople The traits of good salespeople, regardless of the product or service they're pushing. |
The Motley Fool February 1, 2010 Brian Orelli |
Now That's Some Expensive Risk Mitigation Boston Scientific avoids a trial -- but at a dear cost. |
The Motley Fool January 29, 2009 Brian Orelli |
No Buyer's Remorse at Boston Scientific The pacemakers and defibrillators that Guidant contributed to Boston Scientific's bottom line are still growing strong, but the company had to take a whopping $2.7 billion goodwill writedown because the value of what it purchased has changed. |
The Motley Fool May 29, 2008 Brian Orelli |
Medtronic Sticks It to Boston Scientific Medtronic wins the medical-device patent duel with Boston Scientific. |
The Motley Fool April 27, 2004 Nathan Parmelee |
Boston Beer Refreshes The company shows solid numbers and smart leadership. |
The Motley Fool February 3, 2011 Brian Orelli |
Add This Stock to Your Show-Me List Wait for the turnaround before investing in Boston Scientific; if it ever comes. |
The Motley Fool July 28, 2004 Nathan Slaughter |
Investors Toast Boston Beer Boston Beer overcomes slow Sam Adams Light sales and beats Q2 estimates. |
The Motley Fool December 5, 2005 Stephen D. Simpson |
Boston Scientific's Bold Move Acquiring Guidant would be risky, but it would give Boston Scientific exactly what it needs. It will be curious to see how J&J responds to this deal. Investors, take note. |
Inc. November 1, 2000 Jill Andresky Fraser |
Giving Credit to Debt You may think of debt as a drag on your business. But that's not necessarily how the experts see it... |
The Motley Fool July 28, 2011 |
Boston Beer Company Earnings Preview Boston Beer Company will unveil its latest earnings on Tuesday, August 2. |
The Motley Fool February 5, 2008 Brian Orelli |
Boston Scientific Gets Charged Walloped by charges, Boston Scientific posts a loss for the quarter. |
The Motley Fool September 26, 2005 Stephen D. Simpson |
Boston Scientific: Finally Cheap Enough? Could shares of the medical device company now be attractive for long-term investors? |
BusinessWeek October 4, 2004 Gene G. Marcial |
A New Owner For Aspect? Some pros say Aspect Medical Systems may be in play. Shares have leaped to $17, up from $13. |
The Motley Fool October 14, 2005 Stephen D. Simpson |
Boston's Stunts With Stents Tough domestic stent competition is weighing on results from one-trick pony Boston Scientific. The company is in a transitional period and that's at least part of why the stock is down where it is. |
The Motley Fool June 13, 2006 Jim Mueller |
Foolish Investing and Boston Scientific In having bought Guidant, Boston Scientific might end up paying more than just the price. Investors, take note. |
The Motley Fool August 12, 2010 Brian Orelli |
Turnaround Signal, or Just Noise on the Decline? Boston Scientific clears up an FDA warning letter -- four years later. |